What's new

Human medicines European public assessment report (EPAR): Poteligeo, mogamulizumab, Date of authorisation: 22/11/2018, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Poteligeo, mogamulizumab, Date of authorisation: 22/11/2018, Revision: 8, Status: Authorised

May 21, 2025 - 14:55
 0
Human medicines European public assessment report (EPAR): Poteligeo, mogamulizumab, Date of authorisation: 22/11/2018, Revision: 8, Status: Authorised
Human medicines European public assessment report (EPAR): Poteligeo, mogamulizumab, Date of authorisation: 22/11/2018, Revision: 8, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): LysaKare, arginine,lys...

Next Article

‘Behind glide slope’: Navy Reserve chief calls for Congress to step up its KC-13...

Related Posts

Human medicines European public assessment report (EPAR): Vipdomet, alogliptin,metformin, Date of authorisation: 18/09/2013, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

May 19, 2025  0

External guidance on the implementation of the European...

May 15, 2025  0

PSUSA/00010571/202407

PSUSA/00010571/202407

May 12, 2025  0